Masimo Corp Files Definitive Additional Proxy Materials
Ticker: MASI · Form: DEFA14A · Filed: Sep 19, 2024 · CIK: 937556
| Field | Detail |
|---|---|
| Company | Masimo CORP (MASI) |
| Form Type | DEFA14A |
| Filed Date | Sep 19, 2024 |
| Risk Level | low |
| Pages | 7 |
| Reading Time | 8 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, filing-update, corporate-governance
Related Tickers: MASI
TL;DR
MASI filed more proxy docs, no fee. Shareholders get more info for upcoming votes.
AI Summary
Masimo Corporation filed definitive additional materials on September 19, 2024, related to its proxy statement. The filing is a DEFA14A, indicating it's a definitive proxy statement amendment or additional materials. No fee was required for this filing.
Why It Matters
This filing provides updated or supplementary information to shareholders regarding matters to be voted on at a company meeting, impacting corporate governance and shareholder decisions.
Risk Assessment
Risk Level: low — This filing is administrative in nature, providing additional materials for a proxy statement, and does not introduce new financial risks or strategic changes.
Key Players & Entities
- MASIMO CORP (company) — Registrant
- DEFA14A (document) — Filing Type
- 0001213900-24-080007.txt (document) — Filing Identifier
FAQ
What type of filing is this DEFA14A for Masimo Corp?
This is a Definitive Additional Materials filing for Masimo Corp, indicated by the form type DEFA14A.
When was this filing made?
The filing was made on September 19, 2024.
Is Masimo Corp the filer of this document?
Yes, Masimo Corporation is listed as the Registrant and the filer.
Was there a fee required for this filing?
No, the filing indicates that no fee was required.
What is the SIC code for Masimo Corp?
The Standard Industrial Classification (SIC) code for Masimo Corp is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 2,054 words · 8 min read · ~7 pages · Grade level 14.6 · Accepted 2024-09-18 20:49:49
Filing Documents
- ea0215056-defa14a_masimo.htm (DEFA14A) — 33KB
- image_001.jpg (GRAPHIC) — 8KB
- image_002.jpg (GRAPHIC) — 149KB
- image_003.jpg (GRAPHIC) — 313KB
- image_004.jpg (GRAPHIC) — 134KB
- image_005.jpg (GRAPHIC) — 128KB
- image_006.jpg (GRAPHIC) — 124KB
- image_007.jpg (GRAPHIC) — 285KB
- image_008.jpg (GRAPHIC) — 48KB
- 0001213900-24-080007.txt ( ) — 1672KB
Forward-Looking Statements
Forward-Looking Statements This communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) of Masimo and the potential stockholder approval of the Board’s nominees. These forward-looking statements are based on current expectations about future events affecting Masimo and are cause its actual results to differ materially and adversely from those expressed in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding future actions that may be taken by Politan Capital Management LP (“Politan”) in furtherance of its nomination of director candidates for election at the 2024 Annual Meeting, (ii) the potential cost and management distraction attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iii) factors discussed in the “Risk Factors” section of Masimo’s most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), which may be obtained for free at the SEC’s website at www.sec.gov. Although Masimo believes that the expectations reflected in its forward-looking statements are reasonable, the Company does not know whether its expectations will prove correct. All forward-looking statements included in this communication are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only a